Opaleye Management Inc. 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 06:27 am Sale |
2024-12-31 | 13G | Context Therapeutics Inc. CNTX |
Opaleye Management Inc. | 0 0.000% |
-820,000 (Position Closed) |
Filing |
| 2024-01-05 4:05 pm Purchase |
2023-12-27 | 13G | Context Therapeutics Inc. CNTX |
Opaleye Management Inc. | 820,000 5.140% |
820,000 (New Position) |
Filing |